Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $73.66 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $32.57 | 1 | $0 (2024) |
| SANOFI PASTEUR INC. | $20.89 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $20.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.77 | 2 | PFIZER INC. ($32.57) |
| 2017 | $20.89 | 1 | SANOFI PASTEUR INC. ($20.89) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: VACCINES | ||||||
| 03/05/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: ORTHOPEDICS | ||||||
| 08/25/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), ADACEL, FLUZONE | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 738 | 3,182 | $307,064 | $88,958 |
| 2022 | 17 | 667 | 3,910 | $308,834 | $96,563 |
| 2021 | 22 | 767 | 2,907 | $295,496 | $84,141 |
| 2020 | 14 | 455 | 1,416 | $190,813 | $45,425 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 38 | 2,340 | $100,620 | $43,042 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 208 | $56,020 | $14,441 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 77 | $30,429 | $7,829 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $18,314 | $4,149 | 22.7% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 69 | 71 | $8,164 | $3,570 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $12,078 | $3,194 | 26.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 42 | 63 | $14,010 | $3,180 | 22.7% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 27 | 27 | $6,939 | $2,535 | 36.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 22 | $13,200 | $2,293 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $6,389 | $1,662 | 26.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 62 | $4,732 | $718.34 | 15.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 34 | $2,686 | $570.43 | 21.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 12 | 25 | $3,250 | $560.46 | 17.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 18 | 90 | $27,000 | $456.29 | 1.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 20 | 20 | $1,000 | $324.00 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,125 | $181.38 | 16.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 14 | 14 | $733.00 | $166.54 | 22.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 25 | $375.00 | $85.25 | 22.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 50 | 3,180 | $136,740 | $54,272 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 141 | $37,040 | $10,576 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $23,040 | $6,568 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 55 | $21,159 | $5,737 | 27.1% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 87 | 88 | $8,800 | $4,449 | 50.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 20 | $10,506 | $3,070 | 29.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 35 | 55 | $12,720 | $3,050 | 24.0% |
About Dr. Mark Fitzgerald, M.D
Dr. Mark Fitzgerald, M.D is a Family Medicine healthcare provider based in Medway, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1154769842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Fitzgerald, M.D has received a total of $73.66 in payments from pharmaceutical and medical device companies, with $52.77 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($73.66).
As a Medicare-enrolled provider, Fitzgerald has provided services to 2,627 Medicare beneficiaries, totaling 11,415 services with total Medicare billing of $315,087. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Medway, MA
- Active Since 06/05/2013
- Last Updated 09/03/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154769842
Products in Payments
- PREVNAR 20 (Biological) $32.57
- FLUZONE HIGH-DOSE (Drug) $20.89
- EUFLEXXA (Device) $20.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Medway
Dr. Elizabeth Gebhard, D.o, D.O
Family Medicine — Payments: $3,575
Melissa Johnson
Family Medicine — Payments: $533.59
Cheryl Hardenbrook, M.d, M.D
Family Medicine — Payments: $314.86
Patrick Mcsweeney, M.d, M.D
Family Medicine
Kylee Eagles, D.o, D.O
Family Medicine
Dr. Chandler Phillips, M.d, M.D
Family Medicine